Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06575868
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
Myo-inositol During Pregnancy to Prevent Gestational Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Continuous Glucose Monitoring in Myo-inositol Supplemented Obese Pregnant Individuals a Feasibility Pilot Randomized Control Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Myoinositol is an insulin-like compound that is present in both plant and animal cells Humans synthesize it naturally but it is also obtained in our diet It works through an intracellular signaling pathway to increase insulin sensitivity Myoinositol has been used as an over-the-counter OTC supplement in the management of polycystic ovarian syndrome due to this effect Myoinositol has also been shown to improve glycemic profiles in pregnant euglycemic women and well as improve insulin sensitivity in pregnant patients with gestational diabetes mellitus GDM
This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled
This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None